Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - LEGACY LIFEPOINT HEALTH, INC. | d721354dex991.htm |
| EX-99.2 - EX-99.2 - LEGACY LIFEPOINT HEALTH, INC. | d721354dex992.htm |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 1, 2014
LIFEPOINT HOSPITALS, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 000-51251 | 20-1538254 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 330 Seven Springs Way Brentwood, Tennessee |
37027 | |
| (Address of Principal Executive Offices) | (Zip Code) |
(615) 920-8500
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01. | Other Events. |
On May 1, 2014, LifePoint Hospitals, Inc. (the “Company”) issued a press release announcing its intention to sell $400 million in aggregate principal amount of its 5.5% Senior Notes due 2021 through a private offering. On the same date, the Company also announced the pricing of such offering. The notes will be senior unsecured obligations of the Company and will be guaranteed by certain of the Company’s existing and future domestic subsidiaries. The notes will be issued as additional notes under the indenture pursuant to which, on December 6, 2013, the Company issued $700 million in aggregate principal amount of its 5.5% Senior Notes due 2021. The closing of the sale of the notes is expected to occur on May 12, 2014, and is subject to the satisfaction of customary closing conditions. See the Company’s press releases attached as Exhibit 99.1 and 99.2.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 99.1 | Press release issued by the Company on May 1, 2014 announcing proposed add-on offering of $400 million of 5.5% Senior Notes due 2021. | |
| 99.2 | Press release issued by the Company on May 1, 2014 announcing pricing of the add-on offering of $400 million of 5.5% Senior Notes due 2021. | |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| LIFEPOINT HOSPITALS, INC. | ||||
| By: | /s/ Michael S. Coggin | |||
| Name: | Michael S. Coggin | |||
| Title: | Senior Vice President and Chief Accounting Officer | |||
Dated: May 2, 2014
3
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 99.1 | Press release issued by the Company on May 1, 2014 announcing proposed add-on offering of $400 million of 5.5% Senior Notes due 2021. | |
| 99.2 | Press release issued by the Company on May 1, 2014 announcing pricing of the add-on offering of $400 million of 5.5% Senior Notes due 2021. | |
4